BE855022A - Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant - Google Patents

Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant

Info

Publication number
BE855022A
BE855022A BE177890A BE177890A BE855022A BE 855022 A BE855022 A BE 855022A BE 177890 A BE177890 A BE 177890A BE 177890 A BE177890 A BE 177890A BE 855022 A BE855022 A BE 855022A
Authority
BE
Belgium
Prior art keywords
monosubstituents
benzamides
acyl
amino
new
Prior art date
Application number
BE177890A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE855022A publication Critical patent/BE855022A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
BE177890A 1976-05-26 1977-05-25 Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant BE855022A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/690,300 US4044147A (en) 1976-05-26 1976-05-26 N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents

Publications (1)

Publication Number Publication Date
BE855022A true BE855022A (fr) 1977-11-25

Family

ID=24771930

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177890A BE855022A (fr) 1976-05-26 1977-05-25 Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant

Country Status (10)

Country Link
US (1) US4044147A (fr)
JP (1) JPS52144640A (fr)
BE (1) BE855022A (fr)
DE (1) DE2723051C3 (fr)
DK (1) DK223177A (fr)
FR (1) FR2352790A1 (fr)
GB (1) GB1539862A (fr)
IE (1) IE44499B1 (fr)
LU (1) LU77403A1 (fr)
NL (1) NL170135C (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2600513A1 (de) * 1976-01-08 1977-07-28 Hoechst Ag Acylamino(alkyl)benzolderivate und verfahren zu ihrer herstellung
US4500714A (en) * 1981-10-15 1985-02-19 Chugai Seiyaku Kabushiki Kaisha 3-Substituted-ureido-N-pyridyl benzamides
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US5643965A (en) * 1995-04-03 1997-07-01 Centaur Pharmaceuticals, Inc. Aminobenzamide compounds for the treatment of neurodegenerative disorders
US5658953A (en) * 1995-04-03 1997-08-19 Centaur Pharmaceuticals, Inc. Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US5955506A (en) * 1996-04-03 1999-09-21 Centaur Pharmaceuticals, Inc. Benzamides for neurodegenerative disorder treatment
CA2383086A1 (fr) * 1999-09-08 2001-03-15 Joseph P. Steiner Composes non-peptidiques de liaison cyclophiline et leur utilisation
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
CA2613239A1 (fr) * 2005-06-22 2006-12-28 Manne Satyanarayana Reddy Procede ameliore pour la preparation d'ezetimibe
US20070049748A1 (en) * 2005-08-26 2007-03-01 Uppala Venkata Bhaskara R Preparation of ezetimibe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212268C3 (de) * 1971-03-15 1979-09-13 Sumitomo Chemical Co., Ltd., Osaka (Japan) N-Halogenacetylanilinoessigsäureester, Verfahren zu deren Herstellung und diese enthaltende herbicide Massen
JPS50157336A (fr) * 1974-06-11 1975-12-19

Also Published As

Publication number Publication date
IE44499L (en) 1977-11-26
DE2723051B2 (de) 1979-11-22
IE44499B1 (en) 1981-12-16
DK223177A (da) 1977-11-27
NL7705565A (nl) 1977-11-29
GB1539862A (en) 1979-02-07
JPS574626B2 (fr) 1982-01-27
FR2352790A1 (fr) 1977-12-23
DE2723051A1 (de) 1977-12-01
NL170135C (nl) 1982-10-01
LU77403A1 (fr) 1979-01-19
NL170135B (nl) 1982-05-03
FR2352790B1 (fr) 1980-11-14
DE2723051C3 (de) 1980-07-31
JPS52144640A (en) 1977-12-02
US4044147A (en) 1977-08-23

Similar Documents

Publication Publication Date Title
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
LU81349A1 (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
LU80795A1 (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE869793A (fr) Nouveaux derives d'amines et amidines de glycerols et propanediols et medicaments les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
BE855022A (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
BE858608A (fr) Melanges contenant des polydiorganosiloxanes et leur preparation
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
BE863620A (fr) Nouveaux derives 4"-amines d'oleandomycine et medicaments les contenant
BE858147A (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
FR2276292A1 (fr) Melanges liquides d'azonitriles et leur preparation
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE885393A (fr) Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant
BE815584A (fr) Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant
BE883749A (fr) Beta-octamolybdate d'ammelinium et compositions le contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
BE853155A (fr) Nouveaux derives de sucres amines et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19850525